Abstract
Thallium-201 scintigraphy and radionuclide ventriculography with Tc99m-labelled albumin are now routinely used in the diagnosis of a variety of cardiac disorders, to provide information which is mainly directed to morphologic and functional aspects of disease. However, interest in cardiac metabolism has increased as a result of growing concern of the fundamental aspects of heart disease. In the metabolic chain for the production of adenosine triphosphate by the myocardial cell the preferential use of fatty acids as substrate is well established (1–4, 9). An additional diagnostic approach is the use of 123I labelled fatty acids
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bing RJ, Cardiac Metabolism. Physiol. Rev. 45:171, 1965.
Opie LH, Metabolism of the heart in health and disease. Part I. Amer. Heart J. 76: 685, 1968
Neely JR, Rovetto MJ, Oram JF, Myocardial utilization of carbohydrate and lipids. Progr. cardiovasc. Dis. 15: 289, 1972
Neely JR, Morgan HE, Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann. Rev. Physiol. 34: 413, 1974
Evans JR, Gunton RW, Baker RG et al: Use of radioiodinated fatty acid for photoscans of the heart. Circulat. Res. 16: 1, 1965
Robinson GD, Lee AW, Radioiodinated fatty acids for heart imaging: Iodine monochloride addition compared with iodide replacement labelling. J. nucl. Med. 16: 17, 1975
Poe ND, Robinson GD, Graham LS et al, Experimental basis for myocardial imaging with 123I-labeled hexadecanoic acid. J. nucl. Med.. 17: 1077, 1976
Machulla HJ, Stöcklin G, Kupfernagel CH et al, Comparative evaluation of fatty acids labelled with C-11, CI-34m, Br-77 and I-123 for metabolic studies of the myocardium: Concise communication. J. nucl. Med. 19: 298, 1978
Machulla HJ, Marsmann M, Dutschka K, Biochemical concept and synthesis of a radioiodinated phenylfatty acid for in vivo metabolic studies of the myocardium. Eur. J. Nucl. Med. 5:171, 1980.
Freundlieb Ch, Höck A, Vyska K et al, Myocardial imaging and metabolic studies with (17–1231) iodoheptadecanoic acid. J. nucl. Med. 21: 1043, 1980
Vyska K, Höck A, Freundlieb C et al, Stoffwechseluntersuchung am Herzen mit 123J-Fettsäuren und 11C-Methylglukose. Nuklearmedizin 20: 148, 1981.
Höck A, Freundlieb Ch, Vyska K et al, Myocardial imaging and metabolic studies with (17–123I) iodoheptadecanoic acids in patients with idiopathic congestive cardiomyopathy. J. nucl. Med. 24: 22, 1983
Feinendegen LE, Vyska K, Freundlieb Ch et al, Non invasive analysis of metabolic reactions in body tissues, the case of myocardial fatty acids. Eur. J. Nucl. Med. 6: 191, 1981
Van der Wall EE, Den Hollander W, Heidendal GAK et al, Dynamic myocardial scintigraphy with 123l-labeled free fatty acids in patients with myocardial infarction. Eur. J. Nucl. Med. 6: 383, 1981
Van der Wall EE, Heidendal GAK, Den Hollander W et al, Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris. Eur. J. Nucl. Med. 6: 391, 1981
Knapp FF, Ambrose KR, Callahan AP et al, Effects of chain length and Tellurium position on the myocardial uptake of Te-123m fatty acids. J. nucl. Med. 22: 988, 1981
Elmaleh DR, Knapp FF, Yasuda T et al, Myocardial imaging with 9-(Te-123m) Telluroheptadecanoic acid. J. nucl. Med. 22: 994, 1981
Goodman MM, Knapp FF, Callahan AP, et al, A new, well retained myocardial imaging agent: Radioiodinated 15-(p-Iodo- phenyl)-6-Tellurapentadecanoic acid. J. nucl. Med. 23: 904, 1982
Dudczak R . Höfer R, Myocardial scintigraphy with I-123 labeled fatty acids. Summary of a Round Tabel Discussion. J. Radioanal. Chem. 79:329, 1983.
Angelberger P, Wagner-Löffler M, Dudczak R et al, I-123(131) labeled aliphatic and aromatic fätty acids: optimized preparation and biodistribution. In: Radioaktive Isotope in Klinik und Forschung, Vol. 15. Höfer R, Bergmann H (eds), H. Egermann, Vienna, pp 249, 1982
Schmoliner R, Dudczak R, Kronik G et al, Thallium-201-Myokardszintigraphie nach hochdosierter Dipyridamolgabe, Z. Kardiol. 70: 111, 1981
Vogel RA, Quantitative aspects of myocardial perfusion imaging. Seminars Nucl. Med. 10: 146, 1980
Botvinick EH, Dunn RF, Hattner RS et al, A consideration of factors affecting the diagnostic accuracy of thallium 201 myocardial perfusion scintigraphy in detecting coronary artery disease. Seminars Nucl. Med. 10: 157, 1980
Pohost GM, Alpert NM, Ingwall JS et al, Thallium redistribution: Mechanisms and clinical utility. Seminars Nucl. Med. 10: 70, 1980
Dudczak R, Schmoliner R, Angelberger P et al: Myocardial perfusion and metabolism as assessed by Tl-201 and I-123 heptadecanoic acid (HDA) scintigraphy. Nuklearmedizin suppl. 19: 540, 1982
Opie IH, Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Amer. J. Cardiol. 36: 938, 1975
Dudczak R, Schmoliner R, Derfler K et al, Effect of ischemia and pharmacological interventions on the myocardial elimination of I-123 heptadecanoic acid. J. nucl. Med. 23: P34, 1982
Dudczak R, Schmoliner R, Angelberger P et al, Myocardial studies with I-123-p-phenyl-pentadecanoic acid in patients with coronary artery disease (CAD) and cardiomyopathy (CMP). J. nucl. Med. 23: P34, 1982
Dudczak R, Kletter K, Frischauf H et al, Myocardial turnover rates of I-123 heptadecanoic acid (HDA) and I-123 p-phenyl- pentadecanoic acid(p-IPPA). In: Radioaktive Isotope in Klinik und Forschung, Vol. 15. Höfer R, Bergmann H (eds), H. Egermann, Vienna, pp 685, 1982
Reske SN, Sauer W, Machulla HJ et al, 15(p(123I) iodophenyl) pentadecanoic acid as tracer of lipid metabolism: Comparison with (1–14c) palmitic acid in murine tissues. J. nucl. Med. 25: 1335, 1984
Reske SN, Machulla HJ, Winkler C, Metabolism of 15-p (I-123- phenyl)-pentadecanoic acid in hearts of rats. J. nucl. Med. 23: P10, 1982
Coenen HH, Harmand MF, Kloster G et al, 15-(p-75-Br bromo- phenyl) pentadecanoic acid: Pharmacokinetics and potential as heart agent. J. nucl. Med. 22: 891, 1981
Weiss ES, Hoffman EJ, Phelps ME et al, External detection and visualization of myocardial ischemia with 11-C-substrates in vitro and in vivo. Circulat. Res. 39: 24, 1976
Oram JF, Bennetch SL, Neely JR, Regulation of fatty acid utilization in isolated perfused rat hearts. J. Biol. Chem. 248: 5299, 1973
Gordon RS, Cherkes A, Gates H, Unesterified fatty acid in human blood plasma. II. The transport function of unesterifie fatty acid. J. clin. Invest. 36: 810, 1957
Fisher RB, Williamson JR, The effects of insulin, adrenaline and nutrients on the oxygen uptake of the perfused rat heart. J. Physiol. 158: 102, 1961
Schelbert HR, Henze E, Phelps ME, Emission tomography of the heart. Seminars Nucl. Med. 10: 355, 1980
Schön HR, Schelbert HR, Robinson G et al, C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C-11 palmitic acid in normal myocardiui Amer. Heart J. 103: 532, 1982
Schön HR, Schelbert HR, Najafi A et al, C-11 labeled evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C-11 palmitic acid in acutely ischemic myocardium. Amer. Heart J. 103: 548, 1982
Lerch RA, Bergmann SR, Ambos HD et al, Effect of flow-independent reduction of metabolism on regional myocardial clearance of 11C-palmitate. Circulation 65: 731, 1982
Lerch RA, Ambos HD, Bergmann SR et al, Localization of viable, ischemic myocardium by positron-emission tomography with C-11 palmitate. Circulation 64: 689, 1981
Stein O, Stein Y, Lipid synthesis, intracellular transport and storage. Ill Electron microscopic radioautographic study of the rat heart perfused with tritiated oleic acid. J. Cell. Biology 36:63, 1968.
Idell-Wenger JA, Grotyohann LW, Neely JR, Coenzyme A and carnitine distribution in normal and ischemic hearts. J. biol. Chem. 253: 4310, 1978
Crass MF, McCaskill ES, Shipp JC et al, Metabolism of endogenous lipids in cardiac muscle: Effect of pressure development. Amer. J. Physiol. 220: 428, 1971
Gloster J, Harris P, Fatty acid binding to cytoplasmic proteins of myocardium and red and white skeletal muscle in the rat. A possible new role for myoglobin. Biochem. biophys. Res. Commun. 74: 506, 1977
Whitmer JT, Idell-Wenger JA, Rovetto MJ et al, Control of fatty acid metabolism in ischemic and hypoxic hearts. J. biol. Chem. 253: 4305, 1978
McMillin Wood J, Sordahl LA, Lewis RM et al, Effect of chronic myocardial ischemia on the activity of carnitine palmitylcoenzyme. A transferase of isolated canine heart mitochondria. Circul. Res. 32: 340, 1973
Dudczak R, Schmoliner R, Kletter K et al, Clinical evaluation of 123I-labeled p-phenylpentadecanoic acid (p-IPPA) for myocardial scintigraphy. J. nucl. Med. & Biol. 27: 267, 1983
Dudczak R, Myokardszintigraphie mit I-123 markierten Fettsäuren. Wien. Klin. Wschr. 95:Suppl. 143, pp 1–35, 1983.
Lerch RA, Myocardial kinetics of C-11 palmitate and 123I- heptadecanoic acid: Similarities and differences. Workshop on radiolabeled free fatty acids. Amsterdam 6. 7. 1984
Dudczak R, Kletter K, Frischauf H et al, The use of 123I- labeled heptadecanoic acid (HDA) as metabolic tracer: preliminary report. Eur. J. Nucl. Med. 9: 81, 1984
Dudczak R, Homan R, Zangeneh A et al, Myocardial metabolic studies in patients with cardiomyopathy. J. nucl. Med. 24:P20, 1983 (abstr).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Dudczak, R. (1985). Imaging with 123I Labelled Fatty Acids. In: Biersack, H.J., Cox, P.H. (eds) Radioisotope studies in cardiology. Developments in Nuclear Medicine, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5022-1_12
Download citation
DOI: https://doi.org/10.1007/978-94-009-5022-1_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8724-7
Online ISBN: 978-94-009-5022-1
eBook Packages: Springer Book Archive